|
FOR
IMMEDIATE RELEASE
December
11, 2003
Guava
Technologies: Streamlining Cell Based Assays.
Using
samples only a few microlitres in volume the innovative PCA™ (Personal
Cell Analysis) system from Guava Technologies (www.guavatechnologies.com)
enables advanced cell based assays to be started sooner and finished
faster, streamlining the entire research and development process.
As
so little sample is required for each assay, the Guava PCA system
saves precious cells while still giving highly precise and accurate
results. The Guava PCA system improves cell counting and viability
measurements, as well as screening assays used by researchers everywhere
for characterising cells. Its ultra-compact size and ease of use
makes the Guava PCA system indispensable to all scientists who need
immediate access to fast and simple cell culture monitoring and
screening assays.
From
the quick installation and minimal training time required for operation,
to the rapid assay results, the Guava PCA system is designed to
save the operator time, every step of the way. Designed to accelerate
cell-based discovery, the Guava PCA offers turnkey operation in
an integrated system consisting of the compact PCA instrument, software
to automatically analyse and archive data, and optimised reagents.
To accommodate evolving assay needs, the Guava PCA system is expandable.
Current
cell monitoring and screening assays include the ViaCount assay
for cell counting, apoptosis, and viability assessent, all in one
test; the Express assay for a variety of applications, including
protein expression, hybridoma screening, CD marker identification,
bead based supernatant protein/antigen quantification, compound
profiling, intracellular protein expression and GPCR expression,
and three apoptosis assays for the detection of early, mid- and
late apoptotic events.
CONTACTS:
|